Colorcon building film facility in Brazil to cater for growing pharma market

By Gareth Macdonald

- Last updated on GMT

Colorcon building film facility in Brazil to cater for growing pharma market

Related tags Film coating São paulo Brazil

Colorcon is building a film coating production facility in Indaiatuba, Brazil to service markets in South America.

The facility, construction of which is scheduled to complete in October, will produce film coating products for the pharmaceutical and nutritional products under good manufacturing practices (GMP) standards.

When operational in January next year, the Indaiatuba facility will work in concert with Colorcon’s technical laboratory in Cotia, Sao Paulo, which has provided formulation and development services to drug industry customers for 16 years.

A Colorcon spokeswoman said: “Brazil is a key growth market for pharmaceuticals​” adding that the facility will also support customers in other South American markets.

The Indaiatuba plant will be Colorcon’s seventh film coating facility she continued, adding that the firm has film coating facilities in China, Japan, India, UK, US and Puerto Rico.

Colorcon’s most recent investment in Brazil was in 2010 when it added formulation development capacity at the Cotia laboratory.

The addition of two organic solvent processing rooms was prompted by customer demand for formulation development studies.

South America

News of the Brazil plant comes just a few months after Colorcon’s last investment in South America.

In February, the firm opened a formulation laboratory in the Colombian capital Bogota

The facility houses a formulation lab and a service centre and was designed to meet “internationally recognized certification for the containment and safe handling of Level II and Level IV active pharmaceutical ingredients (APIs)”​ according to Colorcon.

The Bogota service centre is Colorcon’s fourth in Latin America. The coating technology and formulation services firm has similar sites in Argentina, Mexico and Brazil.

The firm closed a sales and distribution centre it used to operate in Venezuela and granted distribution rights for pharma customers in the coutry to Algon Corporation.

Related topics Drug delivery & innovation

Related news

Show more

Follow us